Meningeal sarcoma with extracranial metastasis.
7
Citation
0
Reference
10
Related Paper
Cite
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Cite
Citations (6)
Abstract Background Patients undergoing surgery for soft tissue sarcoma have high morbidity rates, particularly after preoperative radiation therapy (RT). An enhanced recovery after surgery (ERAS) programme may improve perioperative outcomes in abdominal surgery. This study reported outcomes of an ERAS programme tailored to patients with soft tissue sarcoma. Methods A prospective ERAS protocol was implemented in 2015 at a high-volume sarcoma centre. Patients treated within the ERAS programme from 2015 to 2018 were case-matched retrospectively with patients treated between 2012 and 2018 without use of the protocol, matched by surgical site, surgeon, sarcoma histology and preoperative RT treatment. Postoperative outcomes, specifically wound complications and duration of hospital stay, were reported. Results In total, 234 patients treated within the ERAS programme were matched with 237 who were not. The ERAS group had lower wound dehiscence rates overall (2 of 234 (0·9 per cent) versus 31 of 237 (13·1 per cent); P < 0·001), after preoperative RT (0 of 41 versus 11 of 51; P = 0·004) and after extremity sarcoma surgery (0 of 54 versus 6 of 56; P = 0·040) compared with the non-ERAS group. Rates of postoperative ileus or obstruction were lower in the ERAS group (21 of 234 (9·9 per cent) versus 40 of 237 (16·9 per cent); P = 0·016) and in those with retroperitoneal sarcoma (4 of 36 versus 15 of 36; P = 0·007). Duration of hospital stay was shorter in the ERAS group (median 5 (range 0–36) versus 6 (0–67) days; P = 0·003). Conclusion Treatment within an ERAS protocol for patients with soft tissue sarcoma was associated with lower morbidity and shorter hospital stay.
Wound dehiscence
Ileus
Cite
Citations (15)
In this study, we sought to review the clinical and histopathological features and the chemotherapy regimens in osteogenic sarcoma in patients over 40 years of age, and we aimed at identifying the possible prognostic factors in this particular group of patients.We reviewed 287 patients with osteosarcoma treated between the year 1986 and 2010. Patients from this group who met the following criteria were considered eligible for our study; presence of primary OS, had typical histological and radiographic features of OS, no prior history of cancer or any treatment elsewhere and no prior history of preexisting bone abnormalities.The Kaplan-Meier survival curve for the entire group, with a 95% confidence interval, at two and five years showed the survival rates as 76.2% and 72.8% respectively. The surgical margin was a significant factor affecting the survival. Presence of a pathological fracture also had a significant effect on the survival rate.Osteogenic sarcoma remains a challenging disease to treat. Despite the expectation that elderly patients may not tolerate aggressive modern chemotherapy as the younger patients, we believe that patients with primary OS over the age of 40 should be treated aggressively with effective chemotherapy and complete surgical excision whenever possible.Level IV, therapeutic study.
Surgical margin
Cite
Citations (5)
Thirty-six patients with primary Ewing's sarcoma of the spine were diagnosed at the Mayo Clinic between 1951 and 1988. The mean age was 17 years (range, 5-40 years). Neurologic symptoms and signs were seen in 58% of the patients. Forty-seven percent of all patients had an open biopsy of the lesion and underwent a decompressive laminectomy. Three of the four patients with thoracic or thoracolumbar involvement had progressive kyphosis after laminectomy. All patients received radiation therapy in various dosages. Sixteen of the patients were registered in the Intergroup Ewing's Sarcoma Study. Intensive combination chemotherapy was administered to 32 of the patients. Nine patients were free of disease at the final follow-up examination (follow-up ranged from 6 to 184 months). The 5-year survival rate was 33%. The mean survival time was 2.9 years. No significant correlation was found between the location of the tumor in the spine and the length of disease-free survival, overall survival, or incidence of metastatic disease. Patients enrolled in the Intergroup Ewing's Sarcoma Study had significantly better rates of disease-free survival and overall survival.
Ewing's sarcoma
Kyphosis
Cite
Citations (147)
A 9-MONTH-OLD boy was referred to a geneticist for evaluation of developmental delay and brachycephaly. Five months prior to his visit, he refused to move one arm, then stopped moving both legs. He could not sit independently and appeared to be in pain when lifted. On examination, the patient had perior-bital edema, diffuse cervical and right inguinal lymphadenopathy, and hepatosplenomegaly. Neurological examination demonstrated decreased head control, decreased strength, and refusal to bear weight. A complete blood cell count showed a hemoglobin level of 52 g/L, a white blood cell count of 0.06×109/L, and a platelet count of 0.03×109/L. The patient was referred to the Department of Hematology-Oncology, and a bone marrow examination showed a blast cell count of 0.33. The diagnosis of acute myeloid leukemia FAB type M4was made. Radiographs of the chest (Figure 1) and left humerus (Figure 2) and a computed tomographic
Hepatosplenomegaly
White blood cell
Brachycephaly
Complete blood count
Bone marrow examination
Hematology
Cite
Citations (0)
The recurrence of melanoma in patients is well-documented, and is dependent on a number of factors. We report a case in which a patient had a case of ganglionar metastasis in the neck after a 30-year disease-free interval following primary treatment.
Primary tumor
Cite
Citations (0)
Cite
Citations (3)
Paraplegia
Thoracic vertebrae
Cite
Citations (0)
Cite
Citations (0)